Abstract Purpose: To update the World Society of the Abdominal Compartment Syndrome (WSACS) consensus definitions and management statements relating to intraabdominal hypertension (IAH) and the abdominal compartment syndrome (ACS). Methods: We conducted systematic or structured reviews to identify relevant studies relating to IAH or ACS. Updated consensus definitions and management statements were then derived using a modified Delphi method and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) guidelines, respectively. Quality of evidence was graded from high (A) to very low (D) and management statements from strong RECOMMENDATIONS (desirable effects clearly outweigh potential undesirable ones) to weaker SUGGESTIONS (potential risks and benefits of the intervention are less clear). Results: In addition to reviewing the consensus definitions proposed in 2006, the WSACS defined the open abdomen, lateralization of the abdominal musculature, polycompartment syndrome, and abdominal compliance, and proposed an open abdomen classification system. RECOMMENDATIONS included intra-abdominal pressure (IAP) measurement, avoidance of sustained IAH, protocolized IAP monitoring and management, decompressive laparotomy for overt ACS, and negative pressure wound therapy and efforts to achieve samehospital-stay fascial closure among patients with an open abdomen. SUGGESTIONS included use of medical therapies and percutaneous catheter drainage for treatment of IAH/ACS, considering the association between body position and IAP, attempts to avoid a positive fluid balance after initial patient resuscitation, use of enhanced ratios of plasma to red blood cells and prophylactic open abdominal strategies, and avoidance of routine early biologic mesh use among patients with open abdominal wounds. NO RECOM-MENDATIONS were possible regarding monitoring of abdominal perfusion pressure or the use of diuretics, renal replacement therapies, albumin, or acute component-parts separation. Conclusion: Although IAH and ACS are common and frequently associated with poor outcomes, the overall quality of evidence available to guide development of RECOMMENDATIONS was generally low. Appropriately designed intervention trials are urgently needed for patients with IAH and ACS.
Introduction
Increased attention to intra-abdominal pressure (IAP), along with changes in the clinical management of critically ill or injured patients, have led to an exponential growth in research relating to intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) in recent years [1, 2] . Milestones have included the incorporation of the World Society of the Abdominal Compartment Syndrome (WSACS; www.WSACS.org), and the Society's publication of IAH and ACS expert consensus definitions in 2006 [3, 4] , clinical practice guidelines in 2007 [5] , and recommendations for research in 2009 [6] . Changes in the management of critically ill surgical and/or medical patients have included increased use of damage control surgery and resuscitation [7] [8] [9] [10] [11] , percutaneous catheter-based and other minimally invasive therapies, early goal-directed therapy for severe sepsis [12, 13] , and a heightened appreciation of the risks of overresuscitation [14, 15] . In light of such developments, the WSACS reviewed the literature and updated their proposed 2006 consensus definitions and 2007 management statements. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for clinical practice guideline developers was used to provide consistency in identifying and rating the quality of available evidence and the strength of management suggestions and recommendations [16] [17] [18] [19] [20] [21] [22] . Although the results of our update is reported concisely here, interested readers may refer to the parent report for details (Supplement 1; see electronic supplementary material, ESM).
Methods

Evaluation of existing 2006 consensus definitions and risk factors
In concordance with the levels of agreement appropriate for consensus [19] , all 2006 expert consensus definitions for which more than 80 % of the members voted to accept ''as is'' were retained, while all those with less than 50 % acceptance were rejected. Definitions with only 50-80 % agreement were revised through ongoing discussion until complete consensus was obtained. Where extensive discussion among subspecialists or other experts was required, special sub-committees were created, including a dedicated Pediatric Guidelines Sub-Committee who reviewed the adult guidelines to determine their generalizability to pediatrics. We also searched the literature to determine which IAH or ACS risk factors proposed in 2006 are now supported by evidence and developed a consensus open abdomen classification system. Further details are presented in Supplement 2 (see ESM).
Development of consensus management statements
We followed GRADE recommendations for guideline developers in order to generate management statements related to IAH/ACS [18] . Using this approach, guidelines committee members first developed structured clinical questions and then defined patient-important outcomes with the assistance of an independent GRADE methodological advisor (R.J.). Questions were based on polling of the WSACS Executive to redundancy and were formulated according to the Patient, Intervention, Comparison, Outcome, and study Design (PICO) format [23] . Systematic review teams subsequently conducted systematic or structured/semi-structured reviews and prepared evidence profiles for each of the identified patient-important outcomes as suggested by GRADE [18, 20, 24] .
Grading of evidence and development of management statements
After each systematic review team had created their initial evidence profile, formal face-to-face meetings among all guideline committee members were held on two separate days immediately preceding and following the Fifth Scientific Congress of the WSACS in Orlando, FL, USA in August 2011. At the Management Guidelines Meeting, each systematic review team formally presented their search methods and evidence profile. In accordance with GRADE guidelines, they then made recommendations to the panel regarding the direction (for/against/no recommendation) and strength (recommend/suggest) of the proposed statement [16-18, 20, 23-26] . Ultimately, the quality of evidence for each outcome was rated along a four-point ordinal scale in which each evidence grade was symbolized by a letter from D to A: very low (D), low (C), moderate (B), and high (A). Further details are presented in Supplements 3 and 4 (see ESM).
Results
Existing consensus definitions and risk factors
The 2013 WSACS consensus definitions are presented in Table 1 . Changes from the previously published 2006 definitions, and the pertinent rationale for such, are outlined in Supplement 5 (see ESM). Risk Factors for IAH and ACS are shown in Table 2 [2, 4, 7, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] .
Classification of the open abdomen
Critical complications which should be considered in managing the open abdomen include [43] : (1) fixation of the abdominal contents (especially of the viscera to the peritoneal sidewalls) and (2) development of enteroatmospheric fistulae (EAF). To facilitate comparison of patient groups with similar determinants of outcomes and complications, a classification scheme of open abdomen complexity is 1. IAP is the steady-state pressure concealed within the abdominal cavity 2. The reference standard for intermittent IAP measurements is via the bladder with a maximal instillation volume of 25 mL of sterile saline 3. IAP should be expressed in mmHg and measured at endexpiration in the supine position after ensuring that abdominal muscle contractions are absent and with the transducer zeroed at the level of the midaxillary line 4. IAP is approximately 5-7 mmHg in critically ill adults 5. IAH is defined by a sustained or repeated pathological elevation in IAP C 12 mmHg 6. ACS is defined as a sustained IAP [ 20 mmHg (with [3, 4, 19, 38, 47] Damage control laparotomy Hypothermia [30] Increased APACHE-II or SOFA score [36, 38] Massive fluid resuscitation or positive fluid balance [2, 27, [29] [30] [31] 36 , 48] Polytransfusion [30] Others/miscellaneous Age [29] Bacteremia Coagulopathy Increased head of bed angle [40] [41] [42] Massive incisional hernia repair Mechanical ventilation [35] Obesity or increased body mass index [2, 28, 48] PEEP [ 10 [28] Peritonitis Pneumonia Sepsis [29, 37] Shock or hypotension [3, 4, 28, 30, 45] References are shown if the presented risk factor is supported at least to some degree by primary literature. Those unsupported by primary literature are based on clinical judgment and/or pathophysiological rationale. The patient populations included in these studies included major trauma patients, general intensive care unit patients, severe acute pancreatitis patients, severe extremity injury patients, and surgical intensive care unit patients. Moreover, some of these studies addressed only patients that were mechanically ventilated, whereas others included mixed cohorts of patients with different ventilation statuses APACHE-II acute physiology and chronic health evaluation-II, PEEP positive end expiratory pressure, SOFA sequential organ failure assessment presented ( Table 3 ). The rationale for creation of this classification system is outlined in Supplement 6 (see ESM).
Pediatric Guidelines Sub-Committee: definitions
A dedicated pediatric sub-committee evaluated the adult definitions for use among children. A summary of the final accepted pediatric definitions is presented in Table 4 . For the four definitions rejected, new definitions were proposed that are specific to pediatric use. The rationale for these definitions is outlined in Supplement 7 (see ESM).
Structured clinical questions and consensus management statements
Consensus management statements are summarized in Table 5 . Each of these statements are denoted below to indicate whether they were unchanged from previous guidelines, a new guideline, or revised from previous guidelines [5] . An associated summary of overall management and medical management algorithms are presented in Figs. 1 and 2, respectively. The summary of findings and rationale for each of the following management statements is described in the supporting Supplements (see ESM).
Should we measure IAP? Should we measure it via the bladder? Should we use an IAP measurement protocol? (Supplement 8; see ESM)
As clinical examination is inaccurate for detecting raised IAP, IAH and ACS research and management rely upon accurate serial or continuous IAP measurements [44] . Although there is an increasing number of IAP measurement techniques, trans-bladder measurement remains a commonly used method, and was recommended by the WSACS in 2006 due to its simplicity and low cost [3, 45] . Abdominal perfusion pressure (APP) may be thought of as the abdominal analogue to cerebral perfusion pressure.
This measure has previously been suggested as a more accurate predictor of visceral perfusion and a better endpoint for resuscitation than IAP or mean arterial pressure (MAP) alone [3, 46] . 
Statement
We could make NO RECOMMENDATION regarding use of APP in the resuscitation or management of the critically ill or injured.
Should we treat or prevent IAH? (Supplement 10; see ESM)
Intra-abdominal hypertension (IAH) has consistently been associated with morbidity and mortality in observational studies. However, it remains uncertain as to whether treating or preventing this condition improves patient outcomes.
Statement
We RECOMMEND efforts and/or protocols to avoid sustained IAH as compared to inattention to IAP among critically ill or injured patients (New Management Recommendation 4 [GRADE 1C]).
How should we manage IAH/ACS?
In addition to decompressive laparotomy for ACS, numerous medical and minimally invasive therapies have been proposed or studied that may be beneficial for patients with IAH or ACS [47] [48] [49] . Approaches or techniques of potential utility include sedation and analgesia, neuromuscular blockade, body positioning, nasogastric/ colonic decompression, promotility agents, diuretics and continuous renal replacement therapies, fluid resuscitation strategies, percutaneous catheter drainage (PCD), and different temporary abdominal closure (TAC) techniques among those requiring an open abdomen [5] .
Non-invasive options: sedation and analgesia (Supplement 11; see ESM)
While sedation and analgesia have been incorporated into previous IAH/ACS management algorithms, it remains unclear if they alter outcomes among those with IAH/ACS.
Statement
We SUGGEST that clinicians ensure that critically ill or injured patients receive optimal pain and anxiety relief (Unchanged Management Suggestion 1 [GRADE 2D]).
Neuromuscular blockade (Supplement 12; see ESM)
Through a reduction in abdominal muscular tone and an increase in abdominal compliance, neuromuscular blockade may reduce IAP among those with IAH and/or ACS [50] .
Statement
We SUGGEST brief trials of neuromuscular blockade as a temporizing measure in the treatment of IAH (Unchanged Management Suggestion 2 [GRADE 2D]).
Body positioning (Supplement 13; see ESM)
Body positioning may change IAP by altering the zero reference for IAP measurement and/or the external forces on the abdominal cavity [32, [40] [41] [42] 51] .
Statement
We SUGGEST that the potential contribution of body position to elevated IAP be considered among patients with, or at risk of, IAH or ACS (Unchanged Management Suggestion 3 [GRADE 2D]).
Nasogastric/colonic decompression (Supplement 14; see ESM)
While the routine use of enteric tubes post-operatively has not been associated with benefit after uncomplicated surgery [52, 53] , there are anecdotal reports that gastric and colonic distension can induce marked IAH commensurate with ACS [52] [53] [54] [55] [56] .
Statement
We SUGGEST liberal use of enteral decompression with nasogastric or rectal tubes when the stomach or colon are dilated in the presence of IAH/ACS (New Management Suggestion 4 [GRADE 1D]).
Promotility agents (Supplement 15; see ESM)
Studies have reported that treatment with neostigmine may be effective at inducing colonic decompression among those with colonic pseudo-obstruction [57] . However, no data exist on the effects of pharmacologic promotility therapy on IAP or outcomes among those with IAH/ACS.
Statement
We SUGGEST that neostigmine be used for the treatment of established colonic ileus not responding to other simple measures and associated with IAH (New Management Suggestion 5 [GRADE 2D]).
Should we keep fluid balance neutral or even negative among ICU patients? (Supplement 16; see ESM)
An increased or positive fluid balance has been associated with third space fluid accumulation and organ dysfunction in animal models [58, 59] . However, it remains unknown whether strategies that target a neutral or even negative fluid balance after the initial resuscitation of critically ill patients may be linked with improved clinical outcomes.
Statement
We SUGGEST using a protocol to try to avoid a positive cumulative fluid balance in the critically ill or injured with, or at risk of, IAH/ACS after the acute resuscitation has been completed and the inciting issues have been addressed (New Management Suggestion 6 [GRADE 2C]).
Diuretics (Supplement 17; see ESM)
Although diuretics are commonly used to improve fluid balance among the critically ill, it remains unknown whether they improve outcomes among those with IAH or ACS.
Statement
We could make NO RECOMMENDATION regarding the use of diuretics to mobilize fluids in hemodynamically stable patients with IAH after acute resuscitation has been completed and the inciting issues have been addressed.
Renal replacement therapies (Supplement 18; see ESM)
Renal replacement therapies are increasingly being used to modify fluid balance among the critically ill.
Statement
We could make NO RECOMMENDATION regarding the use of renal replacement therapies to mobilize fluid in hemodynamically stable patients with IAH after acute resuscitation has been completed and the inciting issues have been addressed.
Albumin (Supplement 19; see ESM)
Albumin is frequently administered to critically ill patients in order to expand plasma volume and improve oncotic pressure [60] .
Statement
We could make NO RECOMMENDATION regarding the administration of albumin versus not, to mobilize fluid in hemodynamically stable patients with IAH after acute resuscitation has been completed and the inciting issues have been addressed.
Should we use damage control resuscitation? (Supplement 20; see ESM)
Damage control resuscitation is increasingly being used among critically injured patients [7, 8, 10, 61] . This type of resuscitation is characterized by permissive hypotension, limitation of crystalloid intravenous fluids, and delivering higher ratios of plasma and platelets to red blood cells [8] .
Statement
We SUGGEST use of an enhanced ratio of plasma/packed red blood cells for resuscitation of massive hemorrhage versus low or no attention to plasma/packed red blood cell ratios (New Management Suggestion 7 [GRADE 2D]).
Minimally-invasive options
If the medical management approaches suggested above do not alleviate IAH, then clinicians will need to consider whether invasive treatments may be necessary.
Should we use PCD? (Supplement 21; see ESM)
Although paracentesis has long been a diagnostic and therapeutic procedure among those without documented IAH, the insertion of an indwelling PCD catheter in an attempt to improve IAP and associated patient-important outcomes among those with IAH/ACS was only first suggested in 2001 [62] .
Statement
We SUGGEST use of PCD to remove fluid (in the setting of obvious intra-peritoneal fluid) in those with IAH/ACS when this is technically possible compared to doing nothing (Unchanged Management Suggestion 8 [GRADE 2C]). We also SUGGEST using PCD to remove fluid (in Decompressive laparotomy historically constituted the standard method to treat severe IAH/ACS and to protect against their development in high risk situations (e.g., following damage control laparotomy for significant intraperitoneal injury) [63, 64] . It has been reported to result in an immediate decrease in IAP and in improvements in organ function [65, 66] . However, decompressive laparotomy is associated with multiple complications and overall reported patient mortality is considerable (up to 50 %), even after decompression [66] .
We RECOMMEND decompressive laparotomy in cases of overt ACS compared to strategies that do not use decompressive laparotomy in critically ill adults with ACS (Unchanged Management Recommendation 5 [GRADE 1D]).
Use of the open abdomen after trauma damage control laparotomy (Supplement 23; see ESM)
The damage control approach to trauma involves an abbreviated resuscitative surgical approach with the primary goal being rapid control of hemorrhage and contamination with restoration of metabolic function at the expense of normal anatomy [8, 63, 64, 67, 68] . Damage control laparotomy is typically a component of a larger damage control approach that includes damage control resuscitation. Although it remains difficult to prove that this approach improves mortality and other outcomes, it has been associated with unexpected patient survival [69, 70] .
Statement
We SUGGEST that patients undergoing laparotomy for trauma suffering from physiologic exhaustion be treated with the prophylactic use of the open abdomen versus closure and expectant IAP management (New Management Suggestion 9 [GRADE 2D]).
Damage control laparotomy for non-trauma acute care surgery patients (Supplement 24; see ESM)
While damage control techniques are being used among non-trauma acute care surgery patients (which largely includes emergency general surgery) [70, 71] , very little evidence exists to support their use, or to support prophylactic open abdominal management afterwards.
Statement
We could make NO RECOMMENDATION regarding the prophylactic use of the open abdomen in non-trauma acute care surgery patients with physiological exhaustion versus intra-operative abdominal fascial closure and expectant IAP management.
Damage control surgery for patients with intraabdominal sepsis (Supplement 25; see ESM)
Intra-abdominal sepsis is a particularly devastating and common form of sepsis, which is commonly associated with development of IAH/ACS [72] [73] [74] .
Statement
We SUGGEST NOT to routinely utilize the open abdomen approach for patients with severe intra-peritoneal contamination undergoing emergency laparotomy for intra-abdominal sepsis unless IAH is a specific concern (New Management Suggestion 10 [GRADE 2B]).
Definitive abdominal closure
While the open abdomen method is a valuable, life-saving tool, the longer the abdomen is open, the greater the potential for morbidity [43, [75] [76] [77] . Thus, specific strategies should be utilized from the first laparotomy that consider prevention of visceral adhesions, loss of soft tissue coverage, lateralization of the abdominal musculature and its fascia, malnutrition, and enteric fistulae [43, 76] . The detailed management of the open abdomen is beyond the scope of this document, for which other recent reviews are available [55, 75, 76, 78] .
Should we attempt to achieve same-hospital-stay closure of the open abdomen? (Supplement 26; see ESM)
As the inability to achieve primary fascial closure after damage control laparotomy has been associated with increased morbidity and reduced quality of life among critically ill adults, efforts to close the abdominal fascia before discharge could potentially lead to improved outcomes.
Statement
We [29, 79, 80] . It may also remove fluid and pro-inflammatory cytokines from the peritoneum, which may reduce abdominal third space volume, the systemic inflammatory response, and resultant organ dysfunction [29, 77-79, 81, 82] . However, others have reported concerns over associations between NPWT and recurrent ACS or intestinal or enteroatmospheric fistulae [83, 84] , especially among those with limited intraabdominal fluid available for removal [85] .
We Advances in tissue recovery and engineering have driven production of a large range of bioprosethic mesh prostheses that provide new options for abdominal wall reconstruction [86] [87] [88] . It has been suggested that these meshes can be used to achieve earlier abdominal fascia closure among those with an open abdomen as they may allow for an increased intra-peritoneal domain without enteric fistula formation [89, 90] .
We SUGGEST that bioprosthethic meshes SHOULD NOT be routinely used in the early closure of the open abdomen compared to alternative strategies (New Management Suggestion 11 [GRADE 2D]).
Pediatric IAH and ACS management
The Pediatric Sub-Committee of the WSACS reviewed the main management guidelines in regard to their applicability and suitability for children. They accepted six guidelines as is, rejected none, but could not make recommendations regarding the suitability for children in the remaining six. Their specific opinions are presented in Table 6 .
Discussion
In this manuscript, the WSACS presented updated consensus definitions and management statements related to IAH/ACS. It was identified that there were topics for which future review was required, including the most accurate/meaningful reference-standard locations for IAP measurement and the definition of ''normal'' values of IAP across various patient populations. Moreover, although the Pediatric Sub-Committee reviewed and made recommendations regarding the appropriateness of the updated consensus definitions and management statements for pediatric patients, further work in this area is needed. Similarly, normal values of IAP among obese and pregnant patients have not yet been adequately defined, and the influence of IAH and ACS in these patients is somewhat poorly understood [91, 92] . Thus, further work among these patient populations is urgently needed. Finally, as overt ACS becomes less common [27] , further research must be performed in order to delineate what role IAH without ACS plays in gut ischemia, bacterial translocation, feeding intolerance, anastomotic and wound breakdown, and neurological dysfunction [93] [94] [95] .
The GRADE system was used to formulate the updated consensus management statements. GRADE is practical in requiring clinical judgements to be made in the context of weighing potential benefits and harms, the burdens of therapy both to the patient and society, and involved costs, with the overall assessment of the quality based on the entire body of evidence, rather than any particular study [96] . Therefore, in the context of making recommendations, the quality of evidence ultimately reflects the degree of confidence that a panel of expert clinicians has in the estimates of effect size [96] . The combined, collective experience is therefore reflected in the RECOMMEN-DATIONS and SUGGESTIONS, wherein the evidence is reflected in the quality of evidence assessment. With this background, these guidelines should be used as guides for any institution or clinician to initiate their care of the critically ill, at all times evaluating the patients' outcomes ideally in a formal research study or at least in an organized fashion. However, these guidelines should not be used as performance measures or quality assurance criteria to censure any physician or institution.
In utilizing these guidelines, clinicians should be aware that there are ongoing developments in medical knowledge. The panelists made great efforts to review the literature broadly, and to be aware of ongoing research that could influence recommendations. However, the reviewers focused on completed peer-reviewed studies that were available in the public domain. Although some studies could have been missed, we feel it unlikely that the exclusion of the results of these studies would significantly alter our provided recommendations. Nonetheless, it is probable that new knowledge will require future revision of this work. Given the lack of high-quality evidence to base decision-making, this is desirable, and thus users are reminded to use these guidelines in the context of knowing their patients, acting at the bedside, and considering new data as it becomes available. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
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